Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in IMMUNITYBIO INC
BNP PARIBAS FINANCIAL MARKETS holds 109,477 shares of IBRX (IMMUNITYBIO INC), worth $839,689 as of 2026-Q1. The position was increased (+180.9% shares). IBRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$839,689
Current Shares
109,477
Total Value Change
+$750,120
Total Shares Change
+74,489
Other major holders of IBRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 109,477 |
+180.9% |
| $839,689 |
| 0.0% |
| $10.00 |
40 |
| 2025-Q4 | Decreased | 38,972 | -29.1% | $77,165 | 0.0% | $1.98 | 0 |
| 2025-Q3 | Increased | 55,005 | +71.2% | $135,312 | 0.0% | $2.57 | 33 |
| 2025-Q2 | Increased | 32,135 | +83.7% | $84,836 | 0.0% | $2.70 | 23 |
| 2025-Q1 | Decreased | 17,492 | -50.0% | $52,651 | 0.0% | $3.14 | 0 |
| 2024-Q4 | New | 34,988 | - | $89,569 | 0.0% | $2.68 | 30 |